When performing cross-classification of samples using EZH2 and ER expression, women with ER expression below the median in normal epithelium and concomitant EZH2 expression above the median displayed even higher risk of breast cancer than if only using EZH2 for classification. Here, EZH2 is linked to breast carcinoma.